Navigation Links
Global BioClinical Welcomes Jennifer Maas as Senior Consultant
Date:5/31/2012

SEATTLE, May 31, 2012 /PRNewswire-iReach/ -- Global BioClinical (GBC) is pleased to announce the addition of Jennifer Maas to the corporate team. Ms. Maas has joined GBC as a Senior Consultant and Clinical Operations Manager.  Formerly a Clinical Research Manager at Epigenomics, Inc., Ms. Maas joins GBC with 10+ years of experience, having been responsible for a variety of clinical research studies, international biorepository operations, and biospecimen informatics.

"We are delighted to have Jen join the team and look forward to her important contributions.  She brings a wealth of proven experience from successfully managing studies for several molecular diagnostic products," says Neil R. Mucci, CEO.

About Global BioClinical:

Global BioClinical (GBC) is a contract consulting and clinical research organization (CRO) with core expertise in organizational and project management, clinical trial planning and execution, and human biospecimens. GBC works with clients in the life sciences and healthcare research sector including early-stage and established medical device and biotechnology companies, pharmaceutical companies, medical centers and health systems, research and academic institutions, government agencies and sub-contractors, venture capital groups, and not-for-profit groups. GBC supports predictive, prognostic, personalized, and participatory medicine with the leading goal of moving healthcare products to the market more quickly, with less risk, and with a greater return on investment.

Contact:

GBC – GLOBAL BIOCLINICAL
Expertise-Based Clinical Research Services
Consulting – Business – Trials – Biospecimens
93 S. Jackson St.
Seattle, WA 98104-2818 U.S.A.
Main:  +1 888 659 1221      
Email: info@globalbioclinical.com 
Web: www.globalbioclinical.com 
Facebook: www.facebook.com/globalbioclinical 
Twitter: www.twitter.com/globalbioclin 
Linked In: www.linkedin.com/company/global-bioclinical

Media Contact: GBC Press Global BioClinical, 888-659-1221, info@globalbioclinical.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global BioClinical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
6. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
7. Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
9. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
10. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
11. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/12/2017)... , May 12, 2017  The China and Canada ... technology that consumes less water, energy and detergent, and features a ... product LaughingU, a shoebox-sized washing machine that washes and sanitizes women,s ... ... LaughingU, is compact, and does not require an external water inlet. ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology:
(Date:5/22/2017)... IL (PRWEB) , ... May 22, 2017 , ... ... is part of a larger group investing in InsightRX, an early stage company ... patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted ...
(Date:5/21/2017)... , ... May 20, 2017 , ... ... systems between ABC Financial Services and financial systems. , Dozens of ... exported files that are electronically processed through GetLinked into their club’s accounting system ...
(Date:5/21/2017)... , ... May 21, 2017 , ... ... has brought together a cross-disciplinary group of scholars, policymakers, and activists wanting to ... Justice, and Equity is the third book from a recent series of ...
(Date:5/21/2017)... ... ... Following the tragic and widely publicized death of Rory Staunton, 12, from undiagnosed ... a protocol to quickly identify and treat the condition. , The mandate led ... saved Rory or anyone else’s life. , Now, five years after the boy’s ...
(Date:5/19/2017)... ... May 19, 2017 , ... A ... University of Charlotte recently began recruitment efforts for the inaugural cohort of its ... the skills, knowledge and expertise to approach and address the unique nuances healthcare ...
Breaking Medicine News(10 mins):